If your pharma line runs at 58 percent OEE and you've been told world-class is 85, you're measuring yourself against a number that was never meant for you. The 85 percent figure comes from Nakajima's 1984 TPM work, built for single-product automotive lines running continuously with almost no changeover. A pharma line with a validated cleaning cycle between every batch, serialization, and in-process checks has structural availability losses that simply don't exist in that model. Chase 85 and you'll burn out a good team hitting a ceiling physics won't let them pass. The useful question is how you compare to real, measured pharma lines of your own type. You can book a demo to see where your lines land.
Forget the 85% Myth. Here's What Pharma Lines Actually Run — by Line Type.
Real measured OEE benchmarks for blister, bottling, cartoning, vial filling, and aseptic lines — median, top quartile, and top decile — from direct-sensor data across 120+ pharma plants, so you benchmark against reality instead of a myth.
A 1984 Automotive Target, Misapplied to Regulated Pharma
The 85 percent world-class benchmark isn't wrong — it's just from a different world. It was developed for high-volume dedicated lines making one product continuously, where the only losses to chase are the preventable ones. Pharma doesn't work that way, and the differences aren't inefficiencies you can fix — they're the cost of making a regulated product safely.
This matters more than a footnote, because applying the wrong benchmark does real damage in two directions. Set 85 as the target for an aseptic line that structurally tops out in the 60s, and you demoralize a team that's actually performing well while sending them chasing losses that aren't recoverable. But the reverse is just as costly: let a bottling line that could reach the mid-70s settle at 61 because "pharma OEE is low anyway," and you leave millions in recoverable capacity on the table. A benchmark is only useful if it's the right one for the line, which is exactly why a single blanket number — high or low — fails every line it's applied to.
The cleaning and changeover cycle between products isn't preventable downtime — it's a mandatory, validated production pause. It caps achievable availability in a way a single-product auto line never faces.
Weight checks, environmental monitoring, and quality holds interrupt the run by design. They protect the patient; they also structurally lower the OEE ceiling.
Track-and-trace adds steps and stop points that a pre-serialization line never had, and they show up as real, unavoidable performance and availability losses.
Many pharma lines run dozens of SKUs, so changeover is frequent and structural — the opposite of the single-product line the 85 percent target assumes.
What Pharma Lines Actually Run — Median, Top Quartile, Top Decile
Here is the core of it. These ranges come from direct-sensor OEE measurement across more than 120 pharmaceutical lines, segmented by line type because the drivers differ so much that a single "pharma OEE" number is meaningless. Find your line type and read across — the median is where most plants sit, the top quartile is a realistic stretch, and the top decile is genuinely excellent for that line. One thing to note before you read: these are all-stops-included, direct-sensor figures. Some methodologies exclude validated scheduled downtime, which lifts the numbers into the 60-to-75 range, and best-in-class US pharma with everything included tops out around 70-78. The figures below are the honest, nothing-excluded version — the one that matches how a sensor actually sees your line.
| Line Type | Median | Top Quartile | Top Decile |
|---|---|---|---|
| Bottling (labeling & capping) | 61% | 72% | 77% |
| Vial / liquid filling | 58% | 70% | 76% |
| Blister (PVC/Al or Al/Al) | 56% | 68% | 74% |
| Cartoning & insert placement | 52% | 64% | 70% |
| Aseptic filling | 45% | 58% | 65% |
A top-decile cartoning line at 70 percent and a median bottling line at 61 percent aren't telling you the cartoner is winning — comparing across formats is meaningless. Cartoning carries more small alignment and feeder stops by nature; aseptic carries sterilization and intervention losses that nothing else does. A 58 percent aseptic line may be top-quartile excellent, while a 58 percent bottling line has real headroom left. The only fair comparison is within your own line type — read down your row, not across to someone else's.
See Where Your Lines Land Against These Benchmarks
iFactory measures OEE by direct sensor, line by line, and places each against its own line-type benchmark — so you know whether a number is a problem or already excellent for that line.
The Structural Reasons Behind the Ranking
The order isn't random. Each line type's median reflects the losses built into how it works — cleaner cycle signals and simpler changeovers push a line higher, while more interventions and alignment steps pull it down. Understanding why your line sits where it does is the first step to knowing which losses are actually recoverable.
Bottling and capping sit at the top because the cycle signal is clean and the operation is relatively continuous. Fewer fiddly alignment steps mean fewer micro-stops, so the structural ceiling is higher than any other packaging format.
Liquid and vial filling runs well when dialed in, but fill-weight precision, format changes, and stoppering add stop points that a simple labeler doesn't carry — landing it just below bottling.
Blister sits mid-pack, and its wide spread is telling: top-quartile blister lines run 18-25 minute changeovers and 20-28 micro-stops a shift, while median lines run 35-50 minute changeovers and 42-55 stops. Same machines, very different results.
Cartoning historically carries more small alignment adjustments and feeder-related stops, which is why its median sits below blister. Top-quartile plants here have invested specifically in feeder reliability and real-time micro-stop visibility.
Aseptic filling structurally sits lowest because sterilization cycles, environmental monitoring, and line interventions are non-negotiable. A "low" aseptic OEE often reflects regulatory reality, not poor performance — which is exactly why benchmarking it against blister would mislead.
Before You Benchmark Anyone, Check How You're Measuring
The most dangerous benchmark mistake isn't picking the wrong target — it's comparing a manual Excel OEE to someone else's automatically measured one. Manual tracking systematically overstates OEE by eight to twelve percentage points, because the losses it can't see are exactly the ones that matter most. If your 68 percent is hand-calculated, it may really be 58.
The dozens of sub-minute stops per shift that drag a blister or cartoning line never make it into a manual log — nobody writes down a 40-second jam. Direct sensors count every one.
Manual performance calculations lean on the nameplate cycle time, not the real one, quietly crediting speed the line never actually achieved.
Short slowdowns and minor quality rejects get rounded off or forgotten by shift-end, so the number that reaches the report is cleaner than the shift really was.
Benchmark an inflated manual number against measured peers and you'll conclude you're fine when you have real headroom — or panic over a gap that's just a measurement artifact.
The Gap Is Operational Practice, Not Better Machines
Here's the finding that should change how you think about the number: the plants in the top quartile aren't there because they bought better equipment. The same machine that runs at median in one plant runs top-decile in another. The 15-to-22-point gap is driven by specific operational practices — the things a plant does, not the capital it spent.
Top-quartile blister lines change over in 18-25 minutes where median lines take 35-50. Half the gap is often just changeover discipline — SMED practice, prepared kits, and clear standard work.
Leaders put a live micro-stop Pareto in front of operators, so the biggest recurring small stop is visible and gets fixed. You can't reduce what you can't see, and micro-stops are invisible on paper.
On cartoning especially, top plants invest in feeder reliability specifically, because that's where their losses concentrate — targeting the actual loss profile, not a generic checklist.
Leaders measure by direct sensor and trust the number, so improvement effort targets the real biggest loss instead of chasing a manual figure that hides where the time actually goes.
Measured by Sensor, Placed Against the Right Benchmark
iFactory captures OEE by direct sensor on each line, splits it into its real availability, performance, and quality losses, and compares each line to its own line-type benchmark rather than a one-size number — so you know what's a genuine problem and what's already excellent for that format.
What Operations Teams Ask About Pharma OEE Benchmarks
Benchmark Your Lines Against Reality, Not a Myth
iFactory measures each pharma line by direct sensor, places it against its own line-type benchmark, and ranks the recoverable losses — so you set targets your team can hit and put improvement effort exactly where the time is really going.
